Cargando…
Granulocyte-colony stimulating factor gene therapy as a novel therapeutics for stroke in a mouse model
BACKGROUND: Global ischemia is the resulting effect of a cardiopulmonary arrest (CPA). Presently there is no effective treatment to address neurological deficits in patients who survived a CPA. Granulocyte-colony stimulating factor is a growth factor (G-CSF) with a plethora of beneficial effects, in...
Autores principales: | Menzie-Suderam, Janet M., Modi, Jigar, Xu, Hongyaun, Bent, Andrew, Trujillo, Paula, Medley, Kristen, Jimenez, Eugenia, Shen, Jessica, Marshall, Michael, Tao, Rui, Prentice, Howard, Wu, Jang-Yen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596942/ https://www.ncbi.nlm.nih.gov/pubmed/33126859 http://dx.doi.org/10.1186/s12929-020-00692-5 |
Ejemplares similares
-
Mode of action of granulocyte-colony stimulating factor (G-CSF) as a novel therapy for stroke in a mouse model
por: Modi, Jigar, et al.
Publicado: (2020) -
The Role of NMDA Receptor Partial Antagonist, Carbamathione, as a Therapeutic Agent for Transient Global Ischemia
por: Modi, Jigar Pravinchandra, et al.
Publicado: (2023) -
Neuroprotective Mechanisms of Taurine against Ischemic Stroke
por: Menzie, Janet, et al.
Publicado: (2013) -
Protection of taurine and granulocyte colony-stimulating factor against excitotoxicity induced by glutamate in primary cortical neurons
por: Pan, Chunliu, et al.
Publicado: (2010) -
Sulindac for stroke treatment: neuroprotective mechanism and therapy
por: Modi, Jigar Pravinchandra, et al.
Publicado: (2014)